e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Unravelling the mechanisms of symptoms and exercise limitationas in disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Metronome-paced hyperventilation, CT measurements and exercise to investigate dynamic hyperinflation contrasting tiotropium versus indacaterol treatment in moderate COPD patients
Danilo Cortozi Berton (Porto Alegre, Brazil), Danilo C. Berton, álvaro Santos, Bruno Hochhegger, Ivo Bohn Jr, Rodrigo Lima, Vanderleia Breda, Paulo Teixeira
Source:
International Congress 2015 – Unravelling the mechanisms of symptoms and exercise limitationas in disease
Session:
Unravelling the mechanisms of symptoms and exercise limitationas in disease
Session type:
Poster Discussion
Number:
1541
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Danilo Cortozi Berton (Porto Alegre, Brazil), Danilo C. Berton, álvaro Santos, Bruno Hochhegger, Ivo Bohn Jr, Rodrigo Lima, Vanderleia Breda, Paulo Teixeira. Metronome-paced hyperventilation, CT measurements and exercise to investigate dynamic hyperinflation contrasting tiotropium versus indacaterol treatment in moderate COPD patients. Eur Respir J 2015; 46: Suppl. 59, 1541
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Efficacy of tiotropium and indacaterol alone or the combination on dynamic lung hyperinflation and exercise tolerance in COPD
Source: International Congress 2014 – Asthma and COPD management
Year: 2014
Effects of tiotropium and salmeterol/fluticasone combination on lung hyperinflation, dyspnea and exercise tolerance in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 33s
Year: 2006
Dual bronchodilation with once-daily QVA149 improves lung function and reduces exacerbations in patients with COPD: The IGNITE trials
Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Year: 2013
Effects of inhaled formoterol on dynamic hyperinflation during and after incremental treadmill exercise in patients with advanced COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 172s
Year: 2006
Pre-exercise inhalation of short-acting ß-agonists (SABA) safely improves exercise performance in severe COPD patients by reducing lung hyperinflation
Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD
Year: 2010
Dual bronchodilation with once-daily QVA149 reduces exacerbations, improves lung function and health status versus glycopyrronium and tiotropium in severe-to-very severe COPD patients: The SPARK study
Source: Annual Congress 2013 –New bronchodilators for COPD management
Year: 2013
Once-daily QVA149 demonstrates superior improvements in patient-reported dyspnea compared to tiotropium in patients with moderate-to-severe COPD: The BLAZE study
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013
Exercise and dyspnoea in COPD
Source: Eur Respir Rev 2006; 15: 72-79
Year: 2006
The fixed-dose combination of tiotropium + olodaterol has a rapid onset of action in patients with COPD
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015
Short-acting bronchodilator reversibility does not predict the response to long-term treatment by indacaterol 150 µg in COPD: REVERBREZ study
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013
A systematic review and meta-analysis of the effect of dual versus mono- long-acting bronchodilator therapy on exercise endurance in COPD
Source: International Congress 2016 – Latest insights into functional capacity and muscle weakness in chronic lung diseases
Year: 2016
Tiotropium as essential maintenance therapy in COPD
Source: Eur Respir Rev 2006; 15: 51-57
Year: 2006
QVA149 improves lung function and reduces exacerbations compared to tiotropium in patients with severe-to-very severe COPD: The SPARK study
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013
LABA/LAMA combination, exercise and lung hyperinflation in COPD: a meta-analysis
Source: International Congress 2017 – COPD management
Year: 2017
The effect of tiotropium on lung dynamic hyperinflation and treadmill exercise capacity in mild to moderate COPD
Source: Annual Congress 2012 - COPD treatments: efficacy and safety
Year: 2012
Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD
Source: Eur Respir J 2004; 23: 832-840
Year: 2004
LABA-LAMA combination is superior to LABA monotherapy in improving the cardiocirculatory responses to treadmill exercise in patients with moderate-to-severe COPD
Source: Annual Congress 2010 - Exercise in COPD
Year: 2010
Acute effects of EPAP on exercise tolerance and dynamic hyperinflation in patients with COPD
Source: Annual Congress 2009 - Treatment modalities in chest physiotherapy
Year: 2009
Comparative effects of formoterol monotherapy versus formoterol
plus
tiotropium on dynamic hyperinflation and exercise tolerance in COPD
Source: Annual Congress 2009 - Influence of interventions and comorbidity on exercise performance
Year: 2009
Patients with severe COPD show significant improvements in dyspnea and lung function with once-daily QVA149: The BLAZE study
Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept